This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Karen K. Steinberg, PhD; S. Jay Smith, MS
Centers for Disease Control and Prevention Atlanta, Ga

JAMA. 1994;272(13):1004-1005.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In Reply.

—We recently published an updated meta-analysis of the effect of estrogen use on risk of breast cancer.¹ In case-control studies with community controls in which only the effect of conjugated equine estrogens was analyzed, risk of breast cancer after 10 years of estrogen increased significantly (at least 15% to 29%).

We then updated the meta-analysis in which we stratified by factors such as family history of breast cancer. When we added three new studies^2-4 to our original analysis,⁵ we found no significant difference in risk between women who had a family history of breast cancer and those who did not. Among estrogen users, the RR was 1.57 (95% CI, 1.14 to 2.15) for women with a family history of breast cancer, and the RR was 1.26 (95% CI, 1.11 to 1.47) for women with no family history. In our original estimate for women with a . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?